Share Twitter LinkedIn Facebook Email Catherine Smith, MD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, @UCSFCancer discusses the prognostic factors in acute myeloid leukemia (AML) and how these factors relate to outcomes for patients. Advertisement
Joe Biden Prostate Cancer Timeline: When Did It Begin? Experts Weigh In Acute Myelogenous Leukemia 4 Mins Read
Transforming AML Treatment: The Breakthrough Precision and Speed of Dr. Gabriel Mannis, MD on the Notable Platform Acute Myelogenous Leukemia 1 Min Read